Boundless Bio Announces First Patient Dosed in First-in-Human Phase 12 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
| BOLD Stock | USD 2.62 0.08 2.96% |
About 61% of Boundless Bio,'s investor base is looking to short. The analysis of the overall investor sentiment regarding Boundless Bio, Common suggests that many traders are alarmed. The current market sentiment, together with Boundless Bio,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Boundless Bio, Common stock news signals to limit their universe of possible portfolio assets.
Boundless |
SAN DIEGO, April 11, 2024--Boundless Bio , a clinical-stage oncology company interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that the first patient has been dosed with BBI-825 in a first-in-human, Phase 12 clinical trial for patients with locally advanced or metastatic cancer with resistance gene amplifications . ecDNA are a key driver of high cop
Read at finance.yahoo.com
 |
Boundless Bio, Fundamental Analysis
We analyze Boundless Bio,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boundless Bio, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boundless Bio, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Boundless Bio, is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Boundless Bio, Common Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Boundless Bio, stock to make a market-neutral strategy. Peer analysis of Boundless Bio, could also be used in its relative valuation, which is a method of valuing Boundless Bio, by comparing valuation metrics with similar companies.
Peers
Boundless Bio, Related Equities
| APGE | Apogee Therapeutics, | 2.65 | ||||
| UG | United Guardian | 1.61 | ||||
| CAH | Cardinal Health | 1.48 | ||||
| CNLFF | Canlan Ice | 0.00 | ||||
| HOFT | Hooker Furniture | 1.56 | ||||
| GNFT | Genfit | 1.84 | ||||
| SAIA | Saia | 2.77 |
Complementary Tools for Boundless Stock analysis
When running Boundless Bio,'s price analysis, check to measure Boundless Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio, is operating at the current time. Most of Boundless Bio,'s value examination focuses on studying past and present price action to predict the probability of Boundless Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio,'s price. Additionally, you may evaluate how the addition of Boundless Bio, to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |